TB screening for high-risk groups in Barcelona
Part of Infections, Lungs & breathing clinical trials.
This trial offers free tuberculosis (TB) testing for people who are at high risk for the disease. It aims to find TB early so it can be treated quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be part of a group that has a higher chance of getting TB
- You must be living in or near Barcelona
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps doctors organize and “stage” tuberculosis (TB) using a structured approach. It may improve how care decisions are made by using confirmed TB information and donated samples/data.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
This study tests health workers for tuberculosis (TB) infection to better understand who is at risk. It may help find ways to protect health workers from TB.
This study tests new tools that can check for tuberculosis (TB) more quickly at or near where care happens. It includes people with cough or TB risk factors, and also the health workers who perform TB testing, to see how well the tests work and how easy they are to use.
This study tests a community-based approach to improve tuberculosis (TB) monitoring and screening for immigrants who recently arrived from specific African and Asian countries. It aims to make TB checkups easier to access and understand.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.